Screener/Healthcare/Biotechnology

GYRE

Gyre Therapeutics, Inc.NASDAQ
$6.97-0.07 (-0.99%)
Small CapUnder $10HealthcareHigh Beta
$6.11
$11.78
$6.91
$7.24
EPS (TTM)$0.03
P/E Ratio232.33
Dividend Yield—
Market Cap$743.5M
Volume90K
Prev Close$7.04
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$30.6M$8.3M$0.0394.7%27.0%
Q2 '25$26.8M$1.6M$0.0095.7%5.9%
Q1 '25$22.1M$3.7M$0.0095.9%16.9%
Q4 '24$27.9M$569K$0.0095.8%2.0%
Q3 '24$25.5M$4.6M$0.0196.2%18.0%
Q2 '24$25.2M$4.5M$0.0196.9%18.0%
Q1 '24$27.2M$9.9M$0.0396.4%36.6%
Get Your Daily Market Recap